Lv1
38 积分 2023-04-03 加入
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
7天前
已完结
Discovery and Evaluation of DA-302168S as an Efficacious Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist
11天前
已完结
Meta-analysis for alterations of IFN-γ, TNF-α and granzyme B levels in vitiligo patients
12天前
已完结
Targeting the elevated IFN-γ in vitiligo patients by human anti- IFN-γ monoclonal antibody hampers direct cytotoxicity in melanocyte
12天前
已完结
Cell-penetrating peptides for therapeutic applications: emerging design strategies and future directions
1个月前
已完结
The case for cell-penetrating peptides
1个月前
已完结
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges
1个月前
已完结
The evolution of the obesity drug market
1个月前
已完结
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
2个月前
已完结
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
2个月前
已完结
皖公网安备34019202002308
